Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes

Details

Serval ID
serval:BIB_37926B477868
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes
Journal
Experimental Cell Research
Author(s)
Busso  N., Collart  M., Vassalli  J. D., Belin  D.
ISSN
0014-4827 (Print)
Publication state
Published
Issued date
12/1987
Volume
173
Number
2
Pages
425-30
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Dec
Abstract
The effect of RU 486, a synthetic steroid that is a powerful antagonist of glucocorticoid hormones, was tested on the transcription of several glucocorticoid-regulated genes in different cell types: inflammatory murine macrophages and two human mammary gland-derived cell lines, MDA-MB-231 and HBL-100. The transcription of genes which are positively regulated by glucocorticoids (e.g., tissue-type plasminogen activator and c-myc in mammary cells, c-fos in macrophages) and that of genes which are negatively regulated by these agents (e.g., urokinase-type plasminogen activator in all three cell types, TNF-a and IL-1 in macrophages) was explored. RU 486 almost completely prevented the effects of dexamethasone on the transcription of these various genes. When added alone, RU 486 had essentially no agonist activity.
Keywords
Animals Cell Line, Transformed Dexamethasone/*antagonists & inhibitors/pharmacology Estrenes/*pharmacology Humans Interleukin-1/genetics Macrophages/enzymology Mice Mifepristone Plasminogen Activators/*genetics/metabolism RNA, Messenger/biosynthesis Tissue Plasminogen Activator/*genetics/metabolism Transcription, Genetic/*drug effects Tumor Cells, Cultured Tumor Necrosis Factor-alpha/genetics Urinary Plasminogen Activator/*genetics/metabolism
Pubmed
Web of science
Create date
25/01/2008 8:29
Last modification date
20/08/2019 13:26
Usage data